Tarsus Pharmaceuticalsinc Stock Fundamentals
TARS Stock | USD 32.76 0.95 2.82% |
Tarsus PharmaceuticalsInc fundamentals help investors to digest information that contributes to Tarsus PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Tarsus Stock. The fundamental analysis module provides a way to measure Tarsus PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tarsus PharmaceuticalsI stock.
At this time, Tarsus PharmaceuticalsI's Total Other Income Expense Net is comparatively stable compared to the past year. Gross Profit is likely to gain to about 21 M in 2024, despite the fact that Net Loss is likely to grow to (102.2 M). Tarsus | Select Account or Indicator |
Tarsus PharmaceuticalsInc Company Return On Equity Analysis
Tarsus PharmaceuticalsI's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tarsus PharmaceuticalsI Return On Equity | -0.7 |
Most of Tarsus PharmaceuticalsI's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tarsus PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Tarsus Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Tarsus PharmaceuticalsInc has a Return On Equity of -0.6971. This is 97.09% lower than that of the Pharmaceuticals sector and 98.09% lower than that of the Health Care industry. The return on equity for all United States stocks is 124.87% higher than that of the company.
Tarsus PharmaceuticalsInc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tarsus PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare Tarsus PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tarsus PharmaceuticalsI competition to find correlations between indicators driving Tarsus PharmaceuticalsI's intrinsic value. More Info.Tarsus PharmaceuticalsInc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Tarsus PharmaceuticalsI's Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Tarsus PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tarsus PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tarsus PharmaceuticalsI's earnings, one of the primary drivers of an investment's value.Tarsus Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tarsus PharmaceuticalsI's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tarsus PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Tarsus PharmaceuticalsI by comparing valuation metrics of similar companies.Tarsus PharmaceuticalsI is currently under evaluation in return on equity category among related companies.
Tarsus Fundamentals
Return On Equity | -0.7 | ||||
Return On Asset | -0.36 | ||||
Operating Margin | (3.40) % | ||||
Current Valuation | 957.81 M | ||||
Shares Outstanding | 37.5 M | ||||
Shares Owned By Insiders | 4.26 % | ||||
Shares Owned By Institutions | 87.93 % | ||||
Number Of Shares Shorted | 7.85 M | ||||
Price To Book | 6.90 X | ||||
Price To Sales | 77.74 X | ||||
Revenue | 17.45 M | ||||
Gross Profit | (17.76 M) | ||||
EBITDA | (142.28 M) | ||||
Net Income | (135.89 M) | ||||
Cash And Equivalents | 245.36 M | ||||
Cash Per Share | 9.20 X | ||||
Total Debt | 31.73 M | ||||
Debt To Equity | 0.09 % | ||||
Current Ratio | 21.36 X | ||||
Book Value Per Share | 5.76 X | ||||
Cash Flow From Operations | (117.49 M) | ||||
Short Ratio | 10.57 X | ||||
Earnings Per Share | (4.62) X | ||||
Price To Earnings To Growth | 0.28 X | ||||
Target Price | 53.38 | ||||
Number Of Employees | 244 | ||||
Beta | 1.05 | ||||
Market Capitalization | 1.26 B | ||||
Total Asset | 266.22 M | ||||
Retained Earnings | (244.66 M) | ||||
Working Capital | 219.19 M | ||||
Net Asset | 266.22 M |
About Tarsus PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tarsus PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tarsus PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tarsus PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 627.3 K | 557.6 K | |
Total Revenue | 17.4 M | 24.5 M | |
Cost Of Revenue | 1.6 M | 1.1 M | |
Stock Based Compensation To Revenue | 1.14 | 1.19 | |
Sales General And Administrative To Revenue | 1.57 | 0.87 | |
Research And Ddevelopement To Revenue | 2.88 | 3.03 | |
Capex To Revenue | (0.32) | (0.30) | |
Revenue Per Share | 0.59 | 0.56 | |
Ebit Per Revenue | (8.21) | (7.80) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tarsus PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tarsus PharmaceuticalsI's short interest history, or implied volatility extrapolated from Tarsus PharmaceuticalsI options trading.
Currently Active Assets on Macroaxis
When determining whether Tarsus PharmaceuticalsInc is a strong investment it is important to analyze Tarsus PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tarsus PharmaceuticalsI's future performance. For an informed investment choice regarding Tarsus Stock, refer to the following important reports:Check out Tarsus PharmaceuticalsI Piotroski F Score and Tarsus PharmaceuticalsI Altman Z Score analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Tarsus Stock analysis
When running Tarsus PharmaceuticalsI's price analysis, check to measure Tarsus PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus PharmaceuticalsI is operating at the current time. Most of Tarsus PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Tarsus PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Tarsus PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Tarsus PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus PharmaceuticalsI. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 0.594 | Quarterly Revenue Growth 0.308 | Return On Assets (0.36) | Return On Equity (0.70) |
The market value of Tarsus PharmaceuticalsInc is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Tarsus PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Tarsus PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.